As ADAM28 is described to be expressed by thymic epithelial cells and as CD8+ T cells are the main effectors in tumor immunity, the migration profiles of differentiated CD8+ T cells from the thymus to their secondary activation sites (spleen and lungs) were investigated. The gene discussed is CD8A; the disease is neoplasm.